Emrah ERASLAN,
Ayşegül İLHAN,
Fatih YILDIZ,
Mutlu DOĞAN
First-line palliative chemotherapy clinical benefit is a key determinant of survival in metastatic uterine leiomyosarcoma
First-line palliative chemotherapy clinical benefit is a key determinant of survival in metastatic uterine leiomyosarcoma
Journal of Health Sciences and Medicine
2021-Cilt: 4 - Sayı: 6
795-799
Metastatic uterine leiomyosarcoma,
Palliative chemotherapy,
Clinical benefit,
Overall survival
108
112